About
Jason Camm is a biotech investor-operator and physician by training who has been publicly identified as Managing Director and Chief Medical Officer at Thiel Capital, where he led biotechnology investing. He is also the founder of Beren Therapeutics P.B.C., where he serves as Founder, Director, President, and CEO. Public profiles and company materials also link him to Thiel Bio Fund, ATAI Life Sciences, Compass Pathways, the Thiel Foundation, and Tufts University's Friedman School.
Areas of interest
biotechdrug discoveryrare diseaseneurodegenerationmental health biotechpsychedelicsmedical philanthropy